Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Purchase
Description
Infliximab, the active ingredient in REMICADE, is a chimeric IgG1κ monoclonal antibody (composed of human constant and murine variable regions) specific for human tumor necrosis factor-alpha (TNFα). It has a molecular weight of approximately 149.1 kilodaltons. Infliximab is produced by a recombinant cell line cultured by continuous perfusion and is purified by a series of steps that includes measures to inactivate and remove viruses.
Infliximab is supplied at a concentration of 10 mg/mL as a sterile, clear and colorless, preservative-free liquid of pH approximately 7.2, which contains 0.61 mg/mL dibasic sodium phosphate, dihydrate, 2.2 mg/mL monobasic sodium phosphate, monohydrate, 0.5 mg /mL polysorbate 80, 50 mg/mL sucrose and Water for Injection.
Properties
Name | Infliximab |
CAS NO. | 170277-31-3 |
Type | Whole antibody |
Source | Chimeric (mouse/human) |
Target | TNF alpha |
Clone | Monoclone |
Formula | C6428H9912N1694O1987S46 |
Molecular Weight | 149 kDa |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China (Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram（Min. Order）.
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Infliximab
